Literature DB >> 32364857

Neonatal Abstinence Syndrome In The United States, 2004-16.

Ashley A Leech1, William O Cooper2, Elizabeth McNeer3, Theresa A Scott4, Stephen W Patrick5.   

Abstract

After increasing for nearly two decades, rates of neonatal abstinence syndrome have recently leveled off, reaching a plateau as early as 2014. These findings may represent successful efforts to prevent and treat opioid use before and during pregnancy.

Entities:  

Keywords:  Access and use; Children’s health; Comorbidity; Drug use; Health conditions; Health policy; Neonatal abstinence syndrome; Opioid use disorder; Pharmaceuticals; Pregnant women; Withdrawal; costs and spending

Mesh：

Substances：

Year:  2020        PMID： 32364857      PMCID： PMC7733618          DOI： 10.1377/hlthaff.2019.00814

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN： 0278-2715            Impact factor:   6.301


  10 in total

1.  Positive Predictive Value of Administrative Data for Neonatal Abstinence Syndrome.

Authors:  Faouzi I Maalouf; William O Cooper; Shannon M Stratton; Judith A Dudley; Jean Ko; Anamika Banerji; Stephen W Patrick
Journal:  Pediatrics       Date:  2018-12-04       Impact factor: 7.124

2.  Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012.

Authors:  S W Patrick; M M Davis; C U Lehman; W O Cooper
Journal:  J Perinatol       Date:  2015-08       Impact factor: 2.521

3.  Medically Assisted Withdrawal (Detoxification): Considering the Mother-Infant Dyad.

Authors:  Hendrée E Jones; Mishka Terplan; Marjorie Meyer
Journal:  J Addict Med       Date:  2017 Mar/Apr       Impact factor: 3.702

4.  A Public Health Response to Opioid Use in Pregnancy.

Authors:  Stephen W Patrick; Davida M Schiff
Journal:  Pediatrics       Date:  2017-02-20       Impact factor: 7.124

5.  Incidence and Costs of Neonatal Abstinence Syndrome Among Infants With Medicaid: 2004-2014.

Authors:  Tyler N A Winkelman; Nicole Villapiano; Katy B Kozhimannil; Matthew M Davis; Stephen W Patrick
Journal:  Pediatrics       Date:  2018-04       Impact factor: 7.124

Review 6.  Public Health Surveillance of Prenatal Opioid Exposure in Mothers and Infants.

Authors:  Margaret A Honein; Coleen Boyle; Robert R Redfield
Journal:  Pediatrics       Date:  2019-01-17       Impact factor: 7.124

7.  Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009.

Authors:  Stephen W Patrick; Robert E Schumacher; Brian D Benneyworth; Elizabeth E Krans; Jennifer M McAllister; Matthew M Davis
Journal:  JAMA       Date:  2012-04-30       Impact factor: 56.272

Review 8.  Neonatal Abstinence Syndrome: Presentation and Treatment Considerations.

Authors:  Karol Kaltenbach; Hendree E Jones
Journal:  J Addict Med       Date:  2016 Jul-Aug       Impact factor: 3.702

9.  Using population data to examine the prevalence and correlates of neonatal abstinence syndrome.

Authors:  Lucy Burns; Richard P Mattick
Journal:  Drug Alcohol Rev       Date:  2007-09

10.  Opioid Use Disorder Documented at Delivery Hospitalization - United States, 1999-2014.

Authors:  Sarah C Haight; Jean Y Ko; Van T Tong; Michele K Bohm; William M Callaghan
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-08-10       Impact factor: 17.586
  10 in total
  11 in total

1.  Effects of Pharmacologic Treatment for Neonatal Abstinence Syndrome on DNA Methylation and Neurobehavior: A Prospective Cohort Study.

Authors:  Marie Camerota; Jonathan M Davis; Lynne M Dansereau; Erica L Oliveira; James F Padbury; Barry M Lester
Journal:  J Pediatr       Date:  2021-12-28       Impact factor: 4.406

2.  Association of Individual and Community Factors With Hepatitis C Infections Among Pregnant People and Newborns.

Authors:  Stephen W Patrick; William D Dupont; Elizabeth McNeer; Melissa McPheeters; William O Cooper; David M Aronoff; Sarah Osmundson; Bradley D Stein
Journal:  JAMA Health Forum       Date:  2021-10-29

3.  Evaluating Definitions for Neonatal Abstinence Syndrome.

Authors:  Kathleen M Doherty; Theresa A Scott; Anna Morad; Travis Crook; Elizabeth McNeer; Kim S Lovell; James C Gay; Stephen W Patrick
Journal:  Pediatrics       Date:  2020-12-02       Impact factor: 7.124

4.  Estimating the impact of neonatal abstinence system interventions on Medicaid: an incremental cost analysis.

Authors:  Diana López-Soto; Paul M Griffin
Journal:  Subst Abuse Treat Prev Policy       Date:  2021-12-20

5.  Prenatal substance use policies and newborn health.

Authors:  Angélica Meinhofer; Allison Witman; Johanna Catherine Maclean; Yuhua Bao
Journal:  Health Econ       Date:  2022-04-20       Impact factor: 2.395

6.  Impact of prenatal substance use policies on commercially insured pregnant females with opioid use disorder.

Authors:  Nadia Tabatabaeepour; Jake R Morgan; Ali Jalali; Shashi N Kapadia; Angélica Meinhofer
Journal:  J Subst Abuse Treat       Date:  2022-05-10

7.  Establishing evidence-based pharmacologic treatments for neonatal abstinence syndrome: A retrospective case study.

Authors:  Sarah K Brewer; Jonathan M Davis; Rachana Singh; Lisa C Welch
Journal:  J Clin Transl Sci       Date:  2022-07-25

8.  Healthcare Patterns of Pregnant Women and Children Affected by OUD in 9 State Medicaid Populations.

Authors:  Marian Jarlenski; Joo Yeon Kim; Katherine A Ahrens; Lindsay Allen; Anna Austin; Andrew J Barnes; Dushka Crane; Paul Lanier; Rachel Mauk; Shamis Mohamoud; Nathan Pauly; Jeffrey Talbert; Kara Zivin; Julie M Donohue
Journal:  J Addict Med       Date:  2021 Sep-Oct 01       Impact factor: 3.702

9.  Development and Validation of a Model to Predict Neonatal Abstinence Syndrome.

Authors:  Stephen W Patrick; James C Slaughter; Frank E Harrell; Peter R Martin; Katherine Hartmann; Judith Dudley; Shannon Stratton; William O Cooper
Journal:  J Pediatr       Date:  2020-10-17       Impact factor: 4.406

10.  Sex and female empowerment (SAFE): A randomized trial comparing sexual health interventions for women in treatment for opioid use disorder.

Authors:  Hendrée E Jones; Caitlin E Martin; Kimberly R Andringa; Rachel Middlesteadt Ellerson; Elisabeth Johnson; Essence Hairston; Kevin E O' Grady
Journal:  Drug Alcohol Depend       Date:  2021-02-17       Impact factor: 4.492
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.